Company profile
ROBEAUTE
Robeauté develops a neurosurgical microrobot intended to navigate brain tissue through a minimally invasive entry point for diagnosis, monitoring and local...
Facts
- Segment
- SURGICAL
- Country
- France
- Headquarters
- Paris
- Founded
- 2017
- Website
- https://www.robeaute.com
About ROBEAUTE
Robeauté develops a neurosurgical microrobot intended to navigate through brain tissue from a minimally invasive entry point. The small articulated device is designed to reach deep or difficult locations for biopsy, monitoring and local delivery of therapy while limiting disruption to surrounding tissue.
The platform combines a miniature robotic mechanism, navigation, imaging and procedure-specific tools under a surgeon's control. Founded in Paris in 2017, Robeauté raised US$28 million in 2025 to advance engineering, preclinical work and preparation for clinical translation. Commercial use remains dependent on successful trials and regulatory clearance.
Market context
DEPLOYMENT
Summary
Type: Medical robotics company
Core: Neurosurgical microrobot
Function: Brain intervention
Audience: Neurosurgeons